Tara Bancroft
Stock Analyst at TD Cowen
(2.74)
# 1,847
Out of 5,182 analysts
11
Total ratings
66.67%
Success rate
20.12%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tara Bancroft
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MLYS Mineralys Therapeutics | Initiates: Buy | n/a | $25.94 | - | 1 | Apr 27, 2026 | |
| PTGX Protagonist Therapeutics | Maintains: Buy | $90 → $100 | $98.07 | +1.97% | 2 | Feb 26, 2026 | |
| OCUL Ocular Therapeutix | Maintains: Buy | $14 → $20 | $9.23 | +116.68% | 4 | Oct 30, 2025 | |
| LNTH Lantheus Holdings | Maintains: Buy | $95 → $80 | $82.63 | -3.18% | 1 | Sep 15, 2025 | |
| TGTX TG Therapeutics | Initiates: Buy | $50 | $35.10 | +42.45% | 1 | Oct 29, 2024 | |
| GERN Geron | Initiates: Buy | $10 | $1.51 | +564.45% | 1 | Apr 29, 2024 | |
| BCYC Bicycle Therapeutics | Initiates: Outperform | n/a | $4.72 | - | 1 | Aug 31, 2022 |
Mineralys Therapeutics
Apr 27, 2026
Initiates: Buy
Price Target: n/a
Current: $25.94
Upside: -
Protagonist Therapeutics
Feb 26, 2026
Maintains: Buy
Price Target: $90 → $100
Current: $98.07
Upside: +1.97%
Ocular Therapeutix
Oct 30, 2025
Maintains: Buy
Price Target: $14 → $20
Current: $9.23
Upside: +116.68%
Lantheus Holdings
Sep 15, 2025
Maintains: Buy
Price Target: $95 → $80
Current: $82.63
Upside: -3.18%
TG Therapeutics
Oct 29, 2024
Initiates: Buy
Price Target: $50
Current: $35.10
Upside: +42.45%
Geron
Apr 29, 2024
Initiates: Buy
Price Target: $10
Current: $1.51
Upside: +564.45%
Bicycle Therapeutics
Aug 31, 2022
Initiates: Outperform
Price Target: n/a
Current: $4.72
Upside: -